This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

SanMedica Internationalâ¿¢ Refuses To Disclose SeroVitalâ¿¢-hgh Celebrity Clientele

NEW YORK, March 27, 2013 /PRNewswire/ -- It's no secret that the rich and famous of Beverly Hills have been visiting some of the most expensive clinics in the world for controversial human growth hormone (hGH) therapy. Why? Because they believe hGH helps reduce body fat, increase lean muscle mass, boost mood, heighten sex drive, give them plenty of energy and get rid of wrinkles... making them look and feel decades — not years, but DECADES — younger. But now rumors are flying that rather than resorting to controversial, expensive, synthetic hGH injections, some celebrities are using a new growth hormone booster called SeroVital™-hgh. But SanMedica International™, SeroVital's distributor, is refusing to cough up the details.

"Of course we have people trying to convince us to release our client list," says Chantelle Daines, spokesperson for SanMedica. "That's inevitable whenever you're involved with celebrities. But we firmly believe that our customers — including the celebrities — are entitled to their privacy, and we are determined to respect that privacy."

Of course, any time celebs make something trendy, the media pays attention, and that has definitely held true for human growth hormone. It seems everyone's been talking about it. hGH has been featured on The Today Show, Good Morning America, Fox News, CNN, The Dr. Oz Show, and in Shape magazine and Vanity Fair. And even though SeroVital-hgh has only been available for about six months, it's already broken records in Parade magazine, been featured in Shape, on Radar Online, and on New York Live, been touted by makeup artists in magazines like Star and OK!... SeroVital has even been seen in the famed New York Times magazine.

But even before the rich and famous began getting their hands on SeroVital-hgh it was making headlines… in obesity research circles, believe it or not. The results of the double-blind, placebo-controlled clinical trial on SeroVital's highly specialized, proprietary, patent-pending key compound were presented for the first time at The Obesity Society's most recent Annual Scientific Meeting in San Antonio, Texas. At this exclusive conference, a group of some of the most renowned research scientists in the world revealed that this tiny little pill was actually capable of increasing mean, serum (blood) growth hormone levels... by an astounding 682%.

This was huge news, because up until this point the best way to increase our hGH levels was through expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, these synthetic hGH injections are also extremely controversial, because some experts fear that introducing synthetic hGH into the body may upset the natural production of hGH.

That's what makes SeroVital-hgh so revolutionary. Rather than introducing synthetic hGH into the body like the injections, SeroVital raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital has not only made it more affordable for people to raise their hGH levels, but has given them a clinically proven way to raise them naturally.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs